
Health Economics Evaluation of Bictegravir/Emtricitabine/Tenofovir for a First-Line Treatment of HIV-1 Infection in ...
Introduction The gravity of the HIV epidemic in China persisted unabated until 2020, with a reported 1.05 million individuals (prevalence: 0.08%) afflicted by HIV, as disclosed by National Center for AIDS/STD Control and Prevention.1 The advent of ART …